Published in World J Gastroenterol on December 28, 2013
The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut (2001) 10.07
Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl (1989) 9.56
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut (2006) 8.08
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet (2009) 5.03
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology (2004) 4.45
Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30 years. Gastroenterology (2012) 3.83
Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centres. Gut (1988) 3.66
Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. Am J Gastroenterol (2005) 2.98
Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease. Gastroenterology (2013) 2.78
Appendectomy is followed by increased risk of Crohn's disease. Gastroenterology (2003) 2.62
AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.31
European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14
Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther (2006) 2.12
AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology (2010) 2.09
Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut (1990) 1.99
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut (2002) 1.96
Increased risk of intestinal cancer in Crohn's disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol (2005) 1.95
European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut (2006) 1.87
A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer (1981) 1.83
The risk of cancer in patients with Crohn's disease. Dis Colon Rectum (2007) 1.80
Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease. Gut (2011) 1.74
The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol (2010) 1.73
Use of thiopurines in the treatment of inflammatory bowel disease is associated with an increased risk of non-melanoma skin cancer in an at-risk population: a cohort study. J Gastroenterol Hepatol (2012) 1.71
Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis (2007) 1.70
Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology (2001) 1.63
Plasma carotenoids and vitamin C concentrations and risk of urothelial cell carcinoma in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr (2012) 1.61
Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study. Gastroenterology (2006) 1.51
Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am (1999) 1.49
Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates. Digestion (2006) 1.49
SCLEROSING CHOLANGITIS; REVIEW OF RECENT CASE REPORTS AND ASSOCIATED DISEASES AND FOUR NEW CASES. Am J Surg (1965) 1.47
Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study. Gastroenterology (1990) 1.43
Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies. Inflamm Bowel Dis (2013) 1.31
Mucocele of the appendix: an unusual cause of lower abdominal pain in a patient with ulcerative colitis. A case report and review of literature. World J Gastroenterol (2005) 1.28
Effects of appendicectomy on the course of ulcerative colitis. Gut (2002) 1.24
Carcinoid tumor and inflammatory bowel disease: a study of eleven cases and review of the literature. Am J Gastroenterol (1997) 1.21
Risk of extra-intestinal cancer in inflammatory bowel disease: meta-analysis of population-based cohort studies. Am J Gastroenterol (2010) 1.21
Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol (1996) 1.17
Significance of appendiceal involvement in patients with ulcerative colitis. Gastrointest Endosc (2002) 1.12
Neuroendocrine neoplasms arising in inflammatory bowel disease: a report of 14 cases. Mod Pathol (1998) 1.08
Appendectomy protects against the development of ulcerative colitis and reduces its recurrence: results of a multicenter case-controlled study in Japan. Am J Gastroenterol (2001) 1.07
Colorectal neoplasia in ulcerative colitis-recent advances. Histopathology (2001) 1.02
Neuroendocrine carcinomas arising in ulcerative colitis: coincidences or possible correlations? World J Gastroenterol (2009) 0.98
Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation. Scand J Gastroenterol (1996) 0.97
Disease activity and cancer risk in inflammatory bowel disease associated with primary sclerosing cholangitis. World J Gastroenterol (2008) 0.96
Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III). J Crohns Colitis (2013) 0.96
Noncolorectal malignancies in inflammatory bowel disease: more than meets the eye. Dig Dis (2009) 0.89
Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study. J Crohns Colitis (2011) 0.87
Fruit and vegetable consumption and risk of aggressive and non-aggressive urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer (2012) 0.86
Macronutrient intake and risk of urothelial cell carcinoma in the European prospective investigation into cancer and nutrition. Int J Cancer (2012) 0.81
Transitional cell carcinoma of the bladder associated with Crohn's disease: case report and review of the literature. Br J Radiol (1992) 0.80
Long-term NSAID use and incident urothelial cell carcinoma in the VITamins and Lifestyle (VITAL) study. Urol Oncol (2012) 0.79
Managing risks of neoplasia in inflammatory bowel disease. Curr Gastroenterol Rep (2012) 0.79
Persistence of urothelial carcinoma of the bladder risk among former smokers: results from a contemporary, prospective cohort study. Urol Oncol (2013) 0.78
Appendiceal mucocele diagnosed in patients with inflammatory bowel disease using endoscopic ultrasound. Case Rep Med (2012) 0.76